Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,092,474
+$336,499 QoQ
Shares Held
134,587
-1.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#115
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INGALLS & SNYDER LLC holds $149,411,802 across 12 Drug Manufacturers - General names. NVS ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,858 | $34,187,307 | |
| 2 | MRK |
Merck & Co., Inc.
|
203,973 | $26,210,530 | |
| 3 | NVS |
Novartis AG
This page
|
134,587 | $21,092,474 | |
| 4 | JNJ |
Johnson & Johnson
|
74,509 | $18,923,050 | |
| 5 | PFE |
Pfizer Inc
|
730,345 | $17,586,707 | |
| 6 | LLY |
ELI LILLY & Co
|
11,055 | $13,259,699 | |
| 7 | AZN |
Astrazeneca PLC
|
29,529 | $5,599,288 | |
| 8 | AMGN |
Amgen Inc
|
14,885 | $5,390,156 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,092,474 | 134,587 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $20,755,975 | 135,882 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $18,312,720 | 132,826 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $16,909,341 | 131,857 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $15,975,377 | 132,017 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $14,074,127 | 126,248 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $11,385,367 | 117,001 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $13,392,238 | 116,434 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $12,160,393 | 114,225 | Shares | Other | 2024-07-31 | |
| 2024-03-31 | $10,859,393 | 112,265 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $11,239,778 | 111,318 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $11,098,767 | 108,961 | Shares | Other | 2023-11-02 | |
| 2023-06-30 | $10,851,659 | 107,538 | Shares | Other | 2023-07-27 | |
| 2023-03-31 | $9,754,392 | 106,026 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $9,580,576 | 105,606 | Shares | Other | 2023-01-31 | |
| 2022-09-30 | $8,170,010 | 107,486 | Shares | Other | 2022-10-21 | |
| 2022-06-30 | $9,164,573 | 108,418 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $9,222,349 | 105,098 | Shares | Other | 2022-05-09 | |
| 2021-12-31 | $8,584,043 | 98,137 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $8,074,793 | 98,738 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $9,077,467 | 99,490 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $8,467,392 | 99,057 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $7,731,928 | 81,880 | Shares | Other | 2021-01-27 | |
| 2020-09-30 | $7,292,465 | 83,860 | Shares | Other | 2020-10-21 | |
| 2020-06-30 | $7,212,100 | 82,575 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $6,521,795 | 79,100 | Shares | Other | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||